New Microchip Sensor Measures Stress Hormones from Drop of Blood

Translate to Spanish or other 102 languages!

A depiction of stress molecules in blood electronically being detected inside nano-wells. By Ella Marushchenko

Mega Doctor News

- Advertisement -

Newswise — New Brunswick, N.J. – A Rutgers-led team of researchers has developed a microchip that can measure stress hormones in real time from a drop of blood. 

The study appears in the journal Science Advances. 

Cortisol and other stress hormones regulate many aspects of our physical and mental health, including sleep quality. High levels of cortisol can result in poor sleep, which increases stress that can contribute to panic attacks, heart attacks and other ailments. 

- Advertisement -

Currently, measuring cortisol takes costly and cumbersome laboratory setups, so the Rutgers-led team looked for a way to monitor its natural fluctuations in daily life and provide patients with feedback that allows them to receive the right treatment at the right time. 

The researchers used the same technologies used to fabricate computer chips to build sensors thinner than a human hair that can detect biomolecules at low levels. They validated the miniaturized device’s performance on 65 blood samples from patients with rheumatoid arthritis. 

“The use of nanosensors allowed us to detect cortisol molecules directly without the need for any other molecules or particles to act as labels,” said lead author Reza Mahmoodi, a postdoctoral scholar in the Department of Electrical and Computer Engineering at Rutgers University-New Brunswick. 

With technologies like the team’s new microchip, patients can monitor their hormone levels and better manage chronic inflammation, stress and other conditions at a lower cost, said senior author Mehdi Javanmard, an associate professor in Rutgers’ Department of Electrical and Computer Engineering. 

- Advertisement -

“Our new sensor produces an accurate and reliable response that allows a continuous readout of cortisol levels for real-time analysis,” he added. “It has great potential to be adapted to non-invasive cortisol measurement in other fluids such as saliva and urine. The fact that molecular labels are not required eliminates the need for large bulky instruments like optical microscopes and plate readers, making the readout instrumentation something you can measure ultimately in a small pocket-sized box or even fit onto a wristband one day.”  The study included Rutgers co-author Pengfei Xie, a Ph.D. student, and researchers from the University of Minnesota and University of Pennsylvania. The research was funded by the DARPA ElectRX program.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Dr. Adrian Billings Warns Rural Texas Healthcare System Is Failing Communities Most in Need

For residents of rural Texas, access to medical care can depend on where they live, whether they have health insurance, and how far they must travel to reach a physician.

STHS Facilities Earn Five-Star Rating for Heart Attack

The national recognition underscores the system's commitment to delivering exceptional cardiac care and life-saving outcomes for Rio Grande Valley patients.

STHS Honors Longtime Employee with Veteran of the Year Award

From serving our nation to caring for patients across the Rio Grande Valley, nearly 100 veterans employed throughout South Texas Health System's (STHS) 12 facilities continue to make a difference through their work in healthcare.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 
- Advertisement -